GOCO
GoHealth, Inc. NASDAQ Listed Jul 15, 2020$1.00
Mkt Cap $28.8M
52w Low $0.99
0.1% of range
52w High $8.75
50d MA $1.39
200d MA $3.15
P/E (TTM)
-0.1x
EV/EBITDA
-2.0x
P/B
—
Debt/Equity
7.1x
ROE
-678.9%
P/FCF
-0.2x
RSI (14)
—
ATR (14)
—
Beta
1.60
50d MA
$1.39
200d MA
$3.15
Avg Volume
70.4K
GoHealth, Inc. operates as a health insurance marketplace and Medicare focused digital health company in the United States. It operates through four segments: Medicare—Internal; Medicare—External; Individual and Family Plans (IFP) and Other—Internal; and IFP and Other—External. The company operates a technology platform that leverages machine-learning algorithms of insurance behavioral data to optimize the process for helping individuals find the health insurance plan for their specific needs. Its products include Medicare Advantage, Medicare Supplement, Medicare prescription drug plans, and Medicare Special Needs Plans; and IFP, dental plans, vision plans, and other ancillary plans to individuals. The company sells its products through carriers and online platform, as well as independent and external agencies. GoHealth, Inc. was founded in 2001 and is headquartered in Chicago, Illinois with additional offices in Charlotte, North Carolina, Lindon, Utah, Bratislava, Slovakia, and Kosice, Slovakia.
214 West Huron Street · Chicago, IL 60654 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2026 | AMC | -2.69 | -1.03 | +61.7% | 1.51 | -1.3% | -11.9% | -15.9% | -16.6% | -23.2% | -25.2% | — |
| Nov 13, 2025 | AMC | -2.06 | -0.19 | +90.8% | 2.61 | +1.9% | -2.7% | -7.3% | -10.3% | -11.9% | -11.9% | — |
| Aug 7, 2025 | AMC | -2.60 | -1.23 | +52.7% | 5.73 | +0.7% | -2.4% | +0.7% | +1.7% | +4.9% | +1.6% | — |
| May 13, 2025 | AMC | -0.26 | -0.47 | -80.8% | 8.11 | +0.9% | -7.5% | -10.6% | -12.1% | -19.9% | -20.8% | — |
| Feb 27, 2025 | AMC | 1.16 | 2.41 | +107.8% | 15.75 | -5.1% | -8.0% | -8.5% | -0.5% | +1.0% | -0.7% | — |
| Nov 7, 2024 | AMC | -3.19 | -3.73 | -16.9% | 11.78 | +0.3% | +1.1% | -2.0% | +7.8% | +5.3% | +5.4% | — |
| Aug 8, 2024 | AMC | -2.47 | -0.75 | +69.6% | 9.15 | +0.2% | -0.8% | -9.7% | -9.5% | -11.8% | -10.6% | — |
| May 9, 2024 | AMC | -0.84 | -0.89 | -6.0% | 9.42 | +0.0% | -4.4% | -8.8% | -7.6% | -6.1% | -5.4% | — |
| Mar 14, 2024 | AMC | 2.73 | 0.60 | -78.0% | 11.34 | +0.0% | +0.2% | -11.7% | -14.4% | -10.4% | -8.8% | — |
| Nov 9, 2023 | AMC | -2.90 | -2.61 | +10.0% | 12.91 | -0.3% | +3.2% | +1.4% | +7.6% | +13.0% | +2.9% | — |
| Aug 10, 2023 | AMC | -2.66 | -1.77 | +33.5% | 18.66 | -0.3% | +2.5% | +2.6% | +2.0% | +3.5% | -1.7% | — |
| May 8, 2023 | AMC | -1.74 | -1.12 | +35.6% | 12.88 | +0.9% | +0.0% | +13.6% | +13.7% | +9.5% | +10.9% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 26 | RBC Capital | Maintains | Sector Perform → Sector Perform | — | $2.93 | $2.91 | -0.7% | +0.0% | +2.4% | -0.7% | +0.0% | +2.0% |
| Nov 20 | Freedom Broker | Maintains | Buy → Buy | — | $2.30 | $2.37 | +3.0% | +0.0% | +11.7% | +21.7% | +27.4% | +27.4% |
| Nov 19 | William Blair | Downgrade | Outperform → Market Perform | — | $2.34 | $2.28 | -2.6% | -1.7% | -1.7% | +9.8% | +19.7% | +25.2% |
| Aug 28 | RBC Capital | Maintains | Sector Perform → Sector Perform | — | $5.30 | $5.32 | +0.4% | -4.0% | -3.6% | -5.8% | -8.7% | -7.7% |
| May 19 | RBC Capital | Maintains | Sector Perform → Sector Perform | — | $7.13 | $6.13 | -14.0% | -8.8% | -10.0% | -16.0% | -18.8% | -19.4% |
| Mar 20 | RBC Capital | Maintains | Sector Perform → Sector Perform | — | $9.71 | $9.63 | -0.8% | +4.6% | +6.5% | +4.1% | +9.9% | +12.4% |
| Apr 4 | Credit Suisse | Maintains | Underperform → Underperform | — | $16.59 | $15.92 | -4.0% | -15.1% | -15.6% | -13.9% | -15.0% | -16.8% |
| Mar 17 | RBC Capital | Maintains | Sector Perform → Sector Perform | — | $17.50 | $15.39 | -12.1% | -24.5% | -22.5% | -11.6% | -13.5% | -19.4% |
| Aug 26 | RBC Capital | Maintains | Sector Perform → Sector Perform | — | $7.61 | $7.35 | -3.4% | -6.2% | -5.8% | -8.5% | -10.9% | -15.6% |
| Aug 16 | Credit Suisse | Maintains | Underperform → Underperform | — | $13.26 | $11.57 | -12.7% | -30.3% | -35.5% | -41.6% | -42.3% | -45.9% |
| Mar 16 | Evercore ISI | Maintains | In Line → In Line | — | $18.00 | $17.10 | -5.0% | +10.8% | +14.2% | +23.3% | +29.2% | +30.0% |
| Mar 16 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $18.00 | $17.10 | -5.0% | +10.8% | +14.2% | +23.3% | +29.2% | +30.0% |
| Mar 3 | RBC Capital | Downgrade | Outperform → Sector Perform | — | $19.95 | $19.80 | -0.8% | -15.0% | -12.0% | -14.3% | -7.5% | -10.5% |
| Mar 2 | Truist | Downgrade | Buy → Hold | — | $29.85 | $21.87 | -26.7% | -33.2% | -43.2% | -41.2% | -42.7% | -38.2% |
| Jan 7 | Credit Suisse | Downgrade | Neutral → Underperform | — | $42.90 | $41.55 | -3.1% | +4.2% | +6.3% | +10.5% | +6.6% | +2.1% |
| Jan 5 | BofA Securities | Downgrade | Buy → Underperform | — | $61.65 | $55.95 | -9.2% | -20.7% | -30.4% | -27.5% | -26.0% | -23.1% |
| Nov 15 | Credit Suisse | Maintains | Neutral → Neutral | — | $66.45 | $66.90 | +0.7% | -1.4% | -1.4% | -9.3% | -14.4% | -18.3% |
| Nov 11 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $70.50 | $72.35 | +2.6% | -4.3% | -5.7% | -7.0% | -7.0% | -14.5% |
| Nov 10 | Barclays | Downgrade | Overweight → Equal Weight | — | $64.95 | $67.80 | +4.4% | +8.5% | +3.9% | +2.3% | +0.9% | +0.9% |
| Nov 10 | RBC Capital | Maintains | Outperform → Outperform | — | $64.95 | $67.80 | +4.4% | +8.5% | +3.9% | +2.3% | +0.9% | +0.9% |
| Nov 9 | Barclays | Downgrade | Overweight → Equal Weight | — | $69.75 | $68.03 | -2.5% | -6.9% | +1.1% | -3.2% | -4.7% | -6.0% |
| Aug 13 | Barclays | Maintains | Overweight → Overweight | — | $70.35 | $70.50 | +0.2% | -13.2% | +6.0% | +0.9% | -0.2% | +4.9% |
| Aug 12 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $123.00 | $94.65 | -23.0% | -42.8% | -50.4% | -39.4% | -42.3% | -42.9% |
| Aug 12 | Raymond James | Downgrade | Outperform → Market Perform | — | $123.00 | $94.65 | -23.0% | -42.8% | -50.4% | -39.4% | -42.3% | -42.9% |
| Aug 12 | Evercore ISI | Downgrade | Outperform → In Line | — | $123.00 | $94.65 | -23.0% | -42.8% | -50.4% | -39.4% | -42.3% | -42.9% |
| Aug 12 | Credit Suisse | Downgrade | Outperform → Neutral | — | $123.00 | $94.65 | -23.0% | -42.8% | -50.4% | -39.4% | -42.3% | -42.9% |
| May 17 | Raymond James | Maintains | Outperform → Outperform | — | $171.60 | $171.15 | -0.3% | -2.0% | +2.3% | +3.1% | +2.6% | +1.6% |
| May 17 | Credit Suisse | Maintains | Outperform → Outperform | — | $171.60 | $171.15 | -0.3% | -2.0% | +2.3% | +3.1% | +2.6% | +1.6% |
| May 14 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $173.40 | $177.60 | +2.4% | -1.0% | -3.0% | +1.2% | +2.1% | +1.6% |
| Mar 15 | Raymond James | Maintains | Outperform → Outperform | — | $153.00 | $158.40 | +3.5% | +13.3% | +11.5% | +14.2% | +18.6% | +17.6% |
| Mar 10 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $156.75 | $161.25 | +2.9% | -3.4% | -0.4% | -2.4% | +10.6% | +8.8% |
| Mar 9 | Credit Suisse | Maintains | Outperform → Outperform | — | $177.90 | $180.00 | +1.2% | -11.9% | -14.9% | -12.2% | -14.0% | -2.5% |
| Nov 16 | Credit Suisse | Maintains | Outperform → Outperform | — | $172.20 | $179.25 | +4.1% | -3.5% | -1.1% | +2.6% | +4.7% | +1.3% |
| Nov 12 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $199.95 | $177.75 | -11.1% | -16.7% | -13.9% | -16.9% | -14.9% | -11.6% |
| Aug 20 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $285.30 | $270.15 | -5.3% | -10.5% | -16.0% | -18.5% | -24.8% | -26.6% |
No insider trades available.
8-K
Unknown — 8-K Filing
GoHealth is strategically retreating from competitive Medicare Advantage markets while doubling down on higher-margin special needs plans and AI investments, signaling management prioritizes profitability and acquisition readiness over growth—a positive pivot for long-term shareholder value.
Mar 31
8-K
Unknown — 8-K Filing
GOCO has 20 business days to regain Nasdaq compliance or faces delisting; this existential threat could eliminate shareholder value entirely if the company fails to resolve underlying violations.
Mar 20
Data updated apr 25, 2026 11:57am
· Source: massive.com